OrganoTherapeutics
Research - Esch-sur-Alzette, Luxembourg, Luxembourg
OrganoTherapeutics Employees
OrganoTherapeutics Senior Management
OrganoTherapeutics Details
OrganoTherapeutics use cutting-edge human-specific mini-brains for the discovery and development of effective drug candidates targeting Parkinson's disease. We screen new molecules on our proprietary human-specific minibrains which represent a model mimicking faithfully the human Parkinson's disease pathology. OrganoTherapeutics aims at developing new drug candidates against Parkinson's disease which are tested in state-of-the art 3D patient models. OrganoTherapeutics has developed first own proprietary drug candidates and has access to attractive libraries for further screening.
OrganoTherapeutics Technologies
Load Balancers
Apache
CMS
WordPress.org
Fonts
Google Font API
Online Video Platforms
YouTube
Other
Mobile Friendly